Yan Zhang | Cardiovascular diseases | Best Researcher Award

Prof. Yan Zhang | Cardiovascular diseases | Best Researcher AwardĀ 

Prof. Yan Zhang, Affiliated Hospital,Liaoning University of Traditional Chinese Medicine, China

Prof. Yan Zhang is a distinguished researcher and medical expert at the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, China. With extensive experience in Traditional Chinese Medicine (TCM), her research focuses on integrative medicine, herbal formulations, and their clinical applications. She has contributed significantly to the advancement of TCM through numerous publications and collaborative projects. Prof. Zhang is dedicated to bridging modern medical practices with ancient healing traditions, enhancing patient care and treatment efficacy. Her work plays a crucial role in promoting evidence-based TCM approaches for various health conditions, fostering innovation in holistic healthcare solutions.

AUTHOR PROFILE

Scopus Profile

āœØ EARLY ACADEMIC PURSUITS:

Prof. Yan Zhang embarked on an illustrious academic journey in Traditional Chinese Medicine (TCM). His foundational education began at Liaoning College of Traditional Chinese Medicine, where he earned a Bachelorā€™s Degree in Traditional Chinese Medicine (1978-1983). His keen interest in advancing his expertise led him to pursue a Masterā€™s Degree in Typhoid Fever (1986-1989) from the same institution. Determined to further his knowledge, he obtained a Ph.D. in Internal Medicine (2001-2004) from Beijing University of Chinese Medicine, one of Chinaā€™s most prestigious institutions for TCM studies.

šŸ‘©ā€šŸŽ“ PROFESSIONAL ENDEAVORS:

Prof. Zhangā€™s professional career spans over four decades, marked by dedication and leadership. His significant roles include:

  • Chief Physician (Since 2012): He has been leading the Cardiopulmonary Department at the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine.
  • Director of the Department of Research (2006-2012): At the same hospital, he oversaw groundbreaking medical research and contributed to numerous advancements in TCM.
  • Director of Internal Medicine (1989-2001): He served as the Director of the Department of Traditional Chinese Medicine Internal Medicine at the Liaoning College of Traditional Chinese Medicine Affiliated Hospital.
  • Early Medical Practice (1983-1986): His career began as a Doctor in the Department of Internal Medicine at Dandong City Traditional Chinese Medicine Hospital.

šŸ“š CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Prof. Zhang is a pioneer in Traditional Chinese Medicine, with a specialized focus on cardiovascular diseases. His research revolves around integrating modern medical techniques with traditional healing practices, making significant strides in the treatment of cardiopulmonary disorders. As an academic leader of Chinaā€™s national key discipline for cardiovascular research, he has spearheaded numerous studies and projects that have influenced the field profoundly.

He is an expert evaluator for major scientific organizations, including:

  • Chinaā€™s National Natural Science Foundation Projects
  • Chinaā€™s National Science and Technology Awards

His contributions have been instrumental in shaping national policies and advancements in TCM research.

šŸŒŸ IMPACT AND INFLUENCE:

Prof. Zhangā€™s influence extends beyond his hospital and university. His expertise has earned him several prestigious accolades, including:

  • Renowned Traditional Chinese Medicine Practitioner of Liaoning Province
  • Outstanding Talent & Expert of Liaoning Province
  • Advanced Scientific and Technological Worker in Liaoning Province
  • Recipient of the Special Allowance of the State Council of China

His mentorship has nurtured numerous doctoral candidates, ensuring that the future of Traditional Chinese Medicine remains in capable hands.

šŸ“š ACADEMIC CITES:

Prof. Zhangā€™s extensive research and scholarly contributions have been widely cited in various national and international medical journals. His work on cardiovascular health, herbal medicine formulations, and the integration of TCM with modern science has set a benchmark for medical professionals worldwide.

šŸŒŸ LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Zhangā€™s legacy in Traditional Chinese Medicine is monumental. His future contributions aim to:

  • Develop new treatment methodologies that combine Western and Eastern medical practices.
  • Mentor the next generation of TCM practitioners.
  • Influence government health policies for the wider acceptance of TCM in mainstream healthcare.
  • Continue his groundbreaking research on cardiovascular diseases.

As a visionary leader in Traditional Chinese Medicine, Prof. Yan Zhangā€™s dedication, research, and teachings will continue to shape the medical landscape for generations to come.

āœØCONCLUSION:

Prof. Yan Zhangā€™s dedication to Traditional Chinese Medicine (TCM) continues to shape the future of integrative healthcare. Through her research, clinical expertise, and innovative approaches, she bridges ancient wisdom with modern medical advancements, ensuring better patient outcomes . Her contributions not only enhance TCMā€™s credibility worldwide but also inspire future generations of practitioners and researchers. With a passion for holistic healing and evidence-based medicine, Prof. Zhang remains a key figure in promoting natural therapies for global health and wellness. Her work stands as a testament to the enduring power of TCM in modern medicine.

TOP NOTABLE PUBLICATION

Mechanism of Ferroptosis in Regulating Chronic Heart Failure and Traditional Chinese Medicine Prevention and Treatment Based on Qi Deficiency and Stagnation: A Review

Journal: Chinese Journal of Experimental Traditional Medical Formulae
Year: 2025

Sara Kaveh | Hypercholesterolemia | Best Researcher Award

Ms. Sara Kaveh | Hypercholesterolemia | Best Researcher Award

Ms. Sara Kaveh, Tehran University of Medical Sciences, Iran

Ms. Sara Kaveh is a dedicated researcher and academic affiliated with Tehran University of Medical Sciences, Iran. Her work focuses on advancing medical research and education within the field of health sciences. She has contributed to various projects aimed at improving healthcare outcomes and is recognized for her commitment to scientific excellence and innovation.

Profile:
Education:

Ms. Sara Kaveh is a PhD candidate in Health Economics at Tehran University of Medical Sciences, where her dissertation explores regionalization models for pancreaticoduodenectomy in Iran, focusing on outcomes and costs. She earned her M.Sc. in Health Technology Assessment from Iran University of Medical Sciences, with a dissertation comparing bevacizumab and its combination with erlotinib for metastatic colorectal cancer. Earlier, she completed an M.Sc. in Health Information Technology at Kerman University of Medical Sciences, investigating the use of the Internet for health information among academic professionals. Her work integrates health economics and technology assessment to enhance healthcare delivery and policy.

ProfessionalĀ  Experience:

 

Ms. Sara Kaveh is currently a Research Assistant at Shiraz University of Medical Sciences, a role she began in November 2023, building on her previous tenure at the same institution from August 2019 to August 2021. From June 2017 to August 2019, she worked as an independent researcher, leading multidisciplinary teams and publishing extensively in high-impact journals. Her research spans health economics and technology assessment, contributing significantly to the academic and practical understanding of healthcare improvements.

Honors and Awards:

Ms. Sara Kaveh achieved notable academic distinctions, securing 4th place in the highly competitive Ph.D. entrance exam in Iran and 6th place in the M.Sc. entrance exam. These rankings underscore her exceptional academic capabilities and commitment to excellence in her field of health economics and technology assessment.

Top Notable Publications:

Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review

Journal: Current Therapeutic Research

Date: September 2024

DOI: 10.1016/j.curtheres.2024.100758

Telehealth impact on biomedical, psychosocial, and behavioural outcomes in patients with diabetes older than 50 years: A systematic synthesis without meta-analysis

Journal: Journal of Telemedicine and Telecare

Date: February 2024

DOI: 10.1177/1357633X211052222

Clinical Characteristics, Laboratory Features, and Outcomes of 151 Pediatric Patients with COVID-19 and MIS-C: A Single-center Study in the Northwest of Iran

Journal: Archives of Pediatric Infectious Diseases

Date: May 7, 2023

DOI: 10.5812/pedinfect-132819

Mobile Health-Based Interventions in Self-care and Treatment Adherence in Older People: A Review Study

Journal: International Journal of Aging

Date: April 27, 2023

DOI: 10.34172/ija.2023.e6

Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2021

DOI: 10.1007/S11096-020-01146-6

WOSUID: WOS:000568149400001

Comparing cardiac troponin levels using sevoflurane and isoflurane in patients undergoing cardiac surgery: a systematic review and meta-analysis

Journal: Journal of Cardiovascular and Thoracic Research

Date: February 12, 2020

DOI: 10.34172/jcvtr.2020.01

Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis

Journal: Clinical Rheumatology

Date: 2020

DOI: 10.1007/S10067-020-04948-1

WOSUID: WOS:000531129700001

Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2019

DOI: 10.1007/S11096-018-0754-1

WOSUID: WOS:000458652000008

Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2019

DOI: 10.1007/S11096-018-00778-Z

WOSUID: WOS:000458652000007

Health technology assessment of Bevacizumab compare with combination of Bevacizumab with Erlotinib for treatment of patients with metastatic colorectal cancer

DOI: 10.22037/IPA.V1I1.20015

The Efficacy of Ivabradine versus Beta Blockers in Comparison of Atenolol and Metoprolol in Patients with Mitral Stenosis in Sinus Rhythm: A Systematic Review and Meta-Analysis

DOI: 10.22037/IPA.V1I1.20006